The package is the result of painstaking negotiations and will give Democrats a chance to hit key policy goals ahead of the upcoming midterm elections.
Once the bill passes the Senate, it needs to be approved by the House of Representatives before President Joe Biden signs it into law. The House is ready to return to take up the bill this Friday, according to House Majority Leader Stenny Hoyer's office.
However, in order for the invoice to pass through the reconciliation process, the package must adhere to a strict set of budgeting rules. And Republicans are using the Vote Alama to put Democrats in place and force a tough political vote.
As expected, key insulin provisions were removed from the bill after the Republican Party voted, resulting in a vote to remove them.
The final vote was 57 to 43. A threshold of 60 votes was required to maintain the stipulation.
Provisions originally included in the bill capped the price of insulin at $35 per month through the private insurance market and Medicare. But senators have ruled that insulin caps in the private insurance market do not comply with the settlement rules Democrats are using to push the bill through Congress.
Democrats kept both provisions in the bill, but Republicans exercised their voting power to force them to void the provisions only from the private market. Medicare's $35 insulin cap remains in place.
Meanwhile, West Virginia Democratic Senator Joe Manchin said Democrats will have several tax provisions in the bill before the House votes on the bill scheduled for Sunday afternoon. It is unclear exactly what is being discussed or how important the changes will be. suggested that it could be submitted.
This story has been updated with additional developments.
